Innvierte commits €11.3M to nine co-investments in July and August

The story so far, in brief; the legwork, and the full article, stay with the original outlet.

CDTI Innovación, the state innovation agency that is the sole shareholder of Innvierte, closed nine co-investments in July and August worth €11,295,000 in total. Each cheque came alongside private investors. The largest went to Barcelona drug developer Nuage Therapeutics (€2.7M, with Sabadell Asabys, Asabys Top Up Fund and Sofinnova Capital X), then Allostery Exploration Technologies, also in Barcelona (€1.8M, with two Sabadell Asabys health funds). Honext Material, which turns paper-recycling sludge into interior building boards, got €1.148M with Meroil, Nolabey Grup, Evolvia and Costrucía.

The rest were smaller: Venter Pharma in Madrid (€991,000, with Diagnostics Investments), Salamanca insect-protein producer Tebrio (€900,000, with Garcia Perez Consulting), Bilbao data-anonymisation firm Nymiz (€252,000, with Swanlaab Tech Fund II), Navarra's MOA Biotech (€225,000, with Swanlaab Innvierte Agrifood Tech) and Barcelona EV-charger maker Vega Energy Technologies (€129,000, with SC Climate Tech Ventures). The ninth, filed under strategic companies, was €3.15M for Madrid's Xoople, which is building a global record of physical changes on Earth, a modest brief.

Since January, Innvierte has co-invested €85.9M in 38 companies and committed €650.1M to 10 investment vehicles. Its running total stands at €3,830.2M across 67 vehicles and €938.1M directly in 197 companies, which makes a summer of €11.3M look like a fairly ordinary couple of months.